Celyad Oncology SA

EBR:CYAD.BR

0.5 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q4
Revenue 0.0140.0580.0440000000000.0050.0060.0020.0020.5972.5180.7790.0353.5050.8858.4830.042.1310.0030.0010.0010.0010.1460.0370.0370.0370.03700000.0140.0140.0140.0140.0070.0070.0070.007
Cost of Revenue 0.0090.0250.4410.4690.97100.67900.84100.9370000.89600000.0110.5260.1290.0270.0260.0130.0010000.1150.0290.0290.0293.1920.6043.1920.6040.6041.6711.6711.6711.6711.4491.4491.4491.449
Gross Profit 0.0050.033-0.397-0.469-0.9710-0.6790-0.8410-0.93700.0050.006-0.8950.0020.5972.5180.7790.0242.9790.7568.4560.0142.1180.0020.0010.0010.0010.0310.0080.0080.008-3.155-0.604-3.192-0.604-0.604-1.657-1.657-1.657-1.657-1.443-1.443-1.443-1.443
Gross Profit Ratio 0.3570.569-9.02300000000011-596.33311110.6860.850.8550.9970.350.9940.6670.6670.6670.6670.2120.2120.2120.212-86.4430000-122.765-122.765-122.765-122.765-214.277-214.277-214.277-214.277
Reseach & Development Expenses 1.5372.5291.7727.8915.5494.9785.545.2775.2174.7395.9044.44110.51911.80111.9876.30812.44111.1366.23711.76111.1475.72712.22915.4466.91911.2245.69211.5425.6929.3353.9666.533.9667.9630.541.0830.540.5400000000
General & Administrative Expenses 1.7372.2183.4894.1753.3932.752.4722.4082.4442.3411.6872.6874.464.2484.1492.1813.6055.0092.3614.1383.3582.084.2853.942.2112.9261.5852.7961.5852.6471.1561.661.1562.5530.6950.890.6950.6950.9280.9280.9280.9280.710.710.710.71
Selling & Marketing Expenses 00.0830.1320.0490.1900.19800.23600.16500.2890.2680.33900.2280.4480.1690.3460.4150.190.2840.4440.1820.3910.2230.50.2230.1920.0990.2020.0990.2060.0520.0520.0520.05200000000
SG&A 1.7372.5853.6354.1943.3932.752.4722.4082.4442.3411.6872.6874.6214.3964.329-7.1494.935.4572.535.0664.2442.275.0044.742.3933.6031.8083.6271.8082.9961.2542.021.2543.0820.7470.890.7470.747-2.696-2.696-2.696-2.696-0.562-0.562-0.562-0.562
Other Expenses -0.186-0.369-0.020.066-1.296-0.235-0.207-1.497-1.300.1050-0.105-0.107-0.01300-8.899-8.899-8.899-8.306-8.306-8.306-9.986-9.986-9.986-7.555-7.555-7.555-7.555-5.461-5.461-5.461-5.4610.1970.1970.1970.19700000000
Operating Expenses 3.0884.7455.42712.0197.6467.4937.8056.1886.3616.5556.4775.75715.24516.30416.329-0.84119.47921.309-0.13143.5416.664-0.30915.917.486-0.67413.885-0.05615.483-0.05610.309-0.2416.43-0.24111.2851.4832.8261.4831.483-2.696-2.696-2.696-2.696-0.562-0.562-0.562-0.562
Operating Income -3.083-4.712-5.824-12.488-6.528-7.549-4.067-7.447-6.103-8.7744.893-5.325-16.135-17.19-17.225-7.074-16.58-15.804-9.341-14.118-12.679-14.072-6.731-17.244-5.876-14.186-7.254-15.174-7.254-10.334-4.108-6.415-4.108-6.937-2.98-6.017-2.98-2.98-0.538-0.538-0.538-0.538-2.284-2.284-2.284-2.284
Operating Income Ratio -220.214-81.241-132.364000000000-3,227-2,865-11,483.333-4,716.167-27.772-6.276-11.995-403.371-3.617-15.901-0.793-431.1-2.758-4,728.667-9,671.333-20,232-9,671.333-70.781-112.541-175.753-112.541-190.0460000-39.862-39.862-39.862-39.862-339.164-339.164-339.164-339.164
Total Other Income Expenses Net 0.004-0.0591.978-0.1677.594-0.024-0.1340.06-0.05-2.225.2560.433-0.4133.1611.054-0.086-2.388-2.655-0.016-27.864-1.735-0.0271.6770.32-0.0270.723-0.025-0.165-0.0250.262-0.0060.034-0.006-1.125-0.106-0.41-0.106-0.10600000000
Income Before Tax -3.079-4.771-3.846-26.947-6.483-7.573-4.261-7.387-6.153-8.7014.824-5.431-16.968-14.029-16.171-7.16-18.968-18.459-9.357-41.982-14.414-14.099-6.688-16.924-5.903-13.775-7.279-15.339-7.279-10.072-4.113-6.381-4.113-8.061-3.087-6.428-3.087-3.087-0.538-0.538-0.538-0.538-2.284-2.284-2.284-2.284
Income Before Tax Ratio -219.929-82.259-87.409000000000-3,393.6-2,338.167-10,780.667-4,773.333-31.772-7.331-12.015-1,199.486-4.112-15.931-0.788-423.1-2.77-4,591.667-9,704.667-20,452-9,704.667-68.986-112.692-174.822-112.692-220.8560000-39.862-39.862-39.862-39.862-339.164-339.164-339.164-339.164
Income Tax Expense -0.0340.063-0.106-0.068-0.109-0.0390.01-0.116-0.027-2.29311.3030.539-0.371-1.362-0.206-0.002-0.0020.0160.0160.0020.001-00.0080.002-0.002-0.0020.0250.0250.0250.0250.0060.0060.0060.0060.1060.1060.1060.10600000000
Net Income -3.044-4.708-3.74-26.879-6.374-7.534-4.271-7.271-6.126-8.7014.824-5.431-16.597-12.667-15.965-7.158-18.968-18.459-9.372-41.98-14.415-14.099-6.68-16.926-5.902-13.775-7.304-15.339-7.304-10.072-4.119-6.381-4.119-8.061-3.193-6.428-3.193-3.193-0.538-0.538-0.538-0.538-2.284-2.284-2.284-2.284
Net Income Ratio -217.429-81.172-85000000000-3,319.4-2,111.167-10,643.333-4,772-31.772-7.331-12.035-1,199.429-4.113-15.931-0.787-423.15-2.77-4,591.667-9,738-20,452-9,738-68.986-112.842-174.822-112.842-220.8560000-39.862-39.862-39.862-39.862-339.164-339.164-339.164-339.164
EPS -0.12-0.16-0.17-1.19-0.29-0.34-0.14-0.49-0.43-0.610.35-0.39-1.19-0.95-1.34-0.57-1.59-1.79-0.84-4.3-1.52-1.47-0.72-1.82-0.63-1.43-0.86-2.1-0.86-1.42-0.61-0.99-0.61-1.27-0.78-3.43-0.78-0.78-0.085-0.085-0.085-0.085-0.36-0.36-0.36-0.36
EPS Diluted -0.12-0.16-0.17-1.19-0.29-0.34-0.14-0.49-0.43-0.610.35-0.39-1.19-0.95-1.34-0.57-1.59-1.79-0.84-4.3-1.52-1.47-0.72-1.82-0.63-1.43-0.86-2.1-0.86-1.42-0.61-0.99-0.61-1.27-0.78-3.43-0.78-0.78-0.085-0.085-0.085-0.085-0.36-0.36-0.36-0.36
EBITDA -2.789-4.468-4.418-26.408-7.602-7.455-8.275-6.073-6.335-6.415-6.476-5.55-15.919-13.053-15.016-6.627-18.592-15.165-9.063-37.981-12.248-11.821-5.952-16.588-5.497-13.707-6.995-14.705-6.995-9.962-3.89-6.002-3.89-6.588-2.759-5.56-2.759-2.759-0.315-0.315-0.315-0.315-1.603-1.603-1.603-1.603
EBITDA Ratio -199.214-77.034-123.341000000000-3,048-2,716.333-10,886-4,418.167-27.085-6.023-11.638-381.629-3.366-13.357-0.702-414.7-2.58-4,569-9,327-19,606.667-9,327-68.233-106.582-164.438-106.582-180.480000-23.31-23.31-23.31-23.31-238.14-238.14-238.14-238.14